Page last updated: 2024-11-05

trihexyphenidyl and Narcosis

trihexyphenidyl has been researched along with Narcosis in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Narcosis: A state of depressed CENTRAL NERVOUS SYSTEM marked by stupor or insensibility.

Research Excerpts

ExcerptRelevanceReference
" Following an evaluation by the psychiatrist, a diagnosis of catatonic schizophrenia was made and he was started on oral sulpiride and benhexol."3.79Neuroleptic malignant syndrome masked by cerebral malaria. ( Rajesh, KM; Sakthi, AN; Sinnathamby, V, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rajesh, KM1
Sinnathamby, V1
Sakthi, AN1

Other Studies

1 other study available for trihexyphenidyl and Narcosis

ArticleYear
Neuroleptic malignant syndrome masked by cerebral malaria.
    BMJ case reports, 2013, May-22, Volume: 2013

    Topics: Adult; Antipsychotic Agents; Delayed Diagnosis; Fatal Outcome; Humans; Malaria, Cerebral; Malaria, F

2013